331 related articles for article (PubMed ID: 35706352)
1. New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network.
Iosifescu AL; Hoogenboom WS; Buczek AJ; Fleysher R; Duong TQ
Int J Methods Psychiatr Res; 2022 Sep; 31(3):e1914. PubMed ID: 35706352
[TBL] [Abstract][Full Text] [Related]
2. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
[TBL] [Abstract][Full Text] [Related]
3. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
[TBL] [Abstract][Full Text] [Related]
4. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
[TBL] [Abstract][Full Text] [Related]
5. Association of post-COVID phenotypic manifestations with new-onset psychiatric disease.
Coleman B; Casiraghi E; Callahan TJ; Blau H; Chan LE; Laraway B; Clark KB; Re'em Y; Gersing KR; Wilkins KJ; Harris NL; Valentini G; Haendel MA; Reese JT; Robinson PN
Transl Psychiatry; 2024 Jun; 14(1):246. PubMed ID: 38851761
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program.
Khullar D; Zhang Y; Zang C; Xu Z; Wang F; Weiner MG; Carton TW; Rothman RL; Block JP; Kaushal R
J Gen Intern Med; 2023 Apr; 38(5):1127-1136. PubMed ID: 36795327
[TBL] [Abstract][Full Text] [Related]
7. Neurological post-acute sequelae of SARS-CoV-2 infection.
Takao M; Ohira M
Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study.
Hill EL; Mehta HB; Sharma S; Mane K; Singh SK; Xie C; Cathey E; Loomba J; Russell S; Spratt H; DeWitt PE; Ammar N; Madlock-Brown C; Brown D; McMurry JA; Chute CG; Haendel MA; Moffitt R; Pfaff ER; Bennett TD; ;
BMC Public Health; 2023 Oct; 23(1):2103. PubMed ID: 37880596
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort.
Yoo SM; Liu TC; Motwani Y; Sim MS; Viswanathan N; Samras N; Hsu F; Wenger NS
J Gen Intern Med; 2022 Jun; 37(8):1988-1995. PubMed ID: 35391623
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.
Sneller MC; Liang CJ; Marques AR; Chung JY; Shanbhag SM; Fontana JR; Raza H; Okeke O; Dewar RL; Higgins BP; Tolstenko K; Kwan RW; Gittens KR; Seamon CA; McCormack G; Shaw JS; Okpali GM; Law M; Trihemasava K; Kennedy BD; Shi V; Justement JS; Buckner CM; Blazkova J; Moir S; Chun TW; Lane HC
Ann Intern Med; 2022 Jul; 175(7):969-979. PubMed ID: 35605238
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection.
Chen S; Liang J; Chen D; Huang Q; Sun K; Zhong Y; Lin B; Kong J; Sun J; Gong C; Wang J; Gao Y; Zhang Q; Sun H
Brain Behav Immun; 2024 Jan; 115():209-222. PubMed ID: 37858739
[TBL] [Abstract][Full Text] [Related]
12. Impact of sleep disruption on cognitive function in patients with postacute sequelae of SARS-CoV-2 infection: initial findings from a Neuro-COVID-19 clinic.
Reid KJ; Ingram LT; Jimenez M; Orban ZS; Abbott SM; Grimaldi D; Knutson KL; Zee PC; Koralnik IJ; Maas MB
Sleep Adv; 2024; 5(1):zpae002. PubMed ID: 38370438
[TBL] [Abstract][Full Text] [Related]
13. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.
Visvabharathy L; Hanson BA; Orban ZS; Lim PH; Palacio NM; Jimenez M; Clark JR; Graham EL; Liotta EM; Tachas G; Penaloza-MacMaster P; Koralnik IJ
Front Immunol; 2023; 14():1155770. PubMed ID: 37313412
[TBL] [Abstract][Full Text] [Related]
14. Post-COVID Phenotypic Manifestations are Associated with New-Onset Psychiatric Disease: Findings from the NIH N3C and RECOVER Studies.
Coleman B; Casiraghi E; Callahan TJ; Blau H; Chan L; Laraway B; Clark KB; Reâ Em Y; Gersing KR; Wilkins K; Harris NL; Valentini G; Haendel MA; Reese J; Robinson PN;
medRxiv; 2022 Nov; ():. PubMed ID: 36380762
[TBL] [Abstract][Full Text] [Related]
15. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
16. Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study.
Scherlinger M; Pijnenburg L; Chatelus E; Arnaud L; Gottenberg JE; Sibilia J; Felten R
Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062706
[TBL] [Abstract][Full Text] [Related]
17. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Leung JM; Wu MJ; Kheradpour P; Chen C; Drake KA; Tong G; Ridaura VK; Zisser HC; Conrad WA; Hudson N; Allen J; Welberry C; Parsy-Kowalska C; Macdonald I; Tapson VF; Moy JN; deFilippi CR; Rosas IO; Basit M; Krishnan JA; Parthasarathy S; Prabhakar BS; Salvatore M; Kim CC
Front Immunol; 2024; 15():1348041. PubMed ID: 38318183
[TBL] [Abstract][Full Text] [Related]
18. Pre-existing conditions associated with post-acute sequelae of COVID-19.
Jacobs ET; Catalfamo CJ; Colombo PM; Khan SM; Austhof E; Cordova-Marks F; Ernst KC; Farland LV; Pogreba-Brown K
J Autoimmun; 2023 Feb; 135():102991. PubMed ID: 36634460
[TBL] [Abstract][Full Text] [Related]
19. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.
Hirschtick JL; Titus AR; Slocum E; Power LE; Hirschtick RE; Elliott MR; McKane P; Fleischer NL
Clin Infect Dis; 2021 Dec; 73(11):2055-2064. PubMed ID: 34007978
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19.
Orban ZS; Visvabharathy L; Perez Giraldo GS; Jimenez M; Koralnik IJ
Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37612134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
